Seer (NASDAQ:SEER – Get Rating) is one of 43 public companies in the “Analytical instruments” industry, but how does it contrast to its peers? We will compare Seer to related businesses based on the strength of its earnings, institutional ownership, analyst recommendations, profitability, valuation, risk and dividends. Analyst Recommendations This is a breakdown of current […]
Seer (NASDAQ:SEER – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its competitors? We will compare Seer to similar companies based on the strength of its analyst recommendations, earnings, institutional ownership, risk, dividends, valuation and profitability. Analyst Recommendations This is a summary […]
Seer (NASDAQ:SEER – Get Rating) is one of 43 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its peers? We will compare Seer to similar businesses based on the strength of its dividends, earnings, valuation, profitability, analyst recommendations, risk and institutional ownership. Profitability This table compares Seer and its peers’ […]
BioForce Nanosciences (OTCMKTS:BFNH – Get Rating) and Seer (NASDAQ:SEER – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership. Profitability This table compares BioForce Nanosciences and Seer’s net margins, […]
Seer (NASDAQ:SEER – Get Rating) is one of 43 public companies in the “Analytical instruments” industry, but how does it contrast to its competitors? We will compare Seer to similar companies based on the strength of its earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and valuation. Insider and Institutional Ownership 86.9% of Seer shares […]